Document is current
Any future updates will be listed below
-
Authors
Lun, Xiao-Kang
Sheng, Kuanwei https://orcid.org/0000-0002-7155-9915
Yu, Xueyang
Lam, Ching Yeung https://orcid.org/0009-0006-4506-5432
Gowri, Gokul https://orcid.org/0000-0003-0911-6889
Serrata, Matthew
Zhai, Yunhao
Su, Hanquan
Luan, Jingyi
Kim, Youngeun
Ingber, Donald E. https://orcid.org/0000-0002-4319-6520
Jackson, Hartland W. https://orcid.org/0000-0001-6423-2415
Yaffe, Michael B. https://orcid.org/0000-0002-9547-3251
Yin, Peng https://orcid.org/0000-0002-2769-6357
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (UH3CA255133)
Foundation for the National Institutes of Health (DP1GM133052)
Foundation for the National Institutes of Health (R01GM124401)
Foundation for the National Institutes of Health (RF1MH124606)
Foundation for the National Institutes of Health (RF1MH128861)
Foundation for the National Institutes of Health (ES028374)
Foundation for the National Institutes of Health (CA226898)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PB_199243)
Ovarian Cancer Research Fund Alliance
Ontario Institute for Cancer Research
- License Information
-
More Information
Article History
Received: 16 February 2023
Accepted: 13 June 2024
First Online: 29 July 2024
Competing interests
: X.-K.L., K.S. and P.Y. are inventors on patent applications covering the ACE method. P.Y. is a cofounder, equity holder, board member and consultant of Ultivue, Inc., Spear Bio, Inc. and Digital Biology Inc. The remaining authors declare no competing interests.
